Compound 724
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1cccc(CN(Cc2ccc(F)cc2)S(=O)(=O)c2cc(Cl)cc(Cl)c2)n1
- IUPAC name:
3,5-dichloro-N-[[6-[[(3,5-dichlorophenyl)sulfonyl-[(4-fluorophenyl)methyl]amino]methyl]pyridin-2-yl]methyl]-N-[(4-fluorophenyl)methyl]-2-hydroxybenzenesulfonamide
- InChi:
InChI=1S/C33H25Cl4F2N3O5S2/c34-23-12-24(35)14-30(13-23)48(44,45)41(17-21-4-8-26(38)9-5-21)19-28-2-1-3-29(40-28)20-42(18-22-6-10-27(39)11-7-22)49(46,47)32-16-25(36)15-31(37)33(32)43/h1-16,43H,17-20H2
- InChiKey:
LBKDIDGLWUKWLL-UHFFFAOYSA-N
External links
44595107 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 91 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 7.38 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 785.00 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 8.32 | |||
TPSA | 107.88 | |||
RB | 10 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 91 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.38 | |
WO2009152082 | 91 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.28 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5037 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4706 | Evatanepag | DB12022 | |
0.4524 | Omidenepag isopropyl | DB15071 | |
0.4483 | PBT-1033 | DB05565 | |
0.4366 | Sulfabenzamide | DB09355 | |
0.4202 | 5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide | DB08211 | |
0.4167 | CGS-27023 | DB07556 | |
0.4158 | Taprenepag | DB12623 | |
0.4140 | Elubrixin | DB12135 | |
0.4126 | Avagacestat | DB11893 | |
0.4121 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4083 | N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DB08631 | |
0.4059 | ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | DB07947 | |
0.4041 | Saccharin | DB12418 | |
0.4022 | Fenquizone | DB13708 |